<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02294773</url>
  </required_header>
  <id_info>
    <org_study_id>13-MIDW-101</org_study_id>
    <nct_id>NCT02294773</nct_id>
  </id_info>
  <brief_title>Study Evaluating the Timing of Intrauterine Insemination in Relation to Positive Home Ovulation Prediction Kit</brief_title>
  <official_title>Randomized Controlled Trial Evaluating the Timing of Intrauterine Insemination in Relation to the LH Surge</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Midwest Fertility Specialists</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Midwest Fertility Specialists</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the impact of the timing of intrauterine insemination
      (IUI) in relation to the natural surge of luteinizing hormone (LH), as detected by home
      ovulation predictor kits, on pregnancy rates per treatment cycle. The study will take place
      at the offices of Midwest Fertility Specialists and include patients who have been
      independently recommended by their primary physician to undergo ovulation induction with
      clomiphene citrate (CC) or letrozole and IUI as therapy for infertility.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intrauterine insemination is a procedure that is performed in the physician's office. During
      the procedure the sperm from the male partner are placed directly into the female partner's
      uterus around the time of ovulation (release of oocyte or egg). Ovulation predictor kits,
      available over the counter at pharmacies, test for the presence of luteinizing hormone in the
      urine. When the test result is a positive, it means the hormone is present in the urine. This
      is a sign of ovulation. Physicians typically choose to perform intrauterine insemination
      either the day of a positive ovulation test or the day after a positive ovulation test. The
      purpose of this study is to determine if the day when intrauterine insemination is performed
      influences the chance of becoming pregnant.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Pregnancies Achieved Per Menstrual Cycle.</measure>
    <time_frame>Up to 3 months</time_frame>
  </primary_outcome>
  <other_outcome>
    <measure>Per Cycle Pregnancy Rate Based on Infertility Diagnosis</measure>
    <time_frame>Up to cycle day 35</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Pregnancy Rate Per Female Partner Age</measure>
    <time_frame>Up to cycle day 35</time_frame>
    <description>Pregnancy rate will be compared between patients &lt;35 and &gt;35 at time of study entry.</description>
  </other_outcome>
  <other_outcome>
    <measure>Pregnancy Rate Per Semen Morphology Score</measure>
    <time_frame>Up to cycle day 35</time_frame>
    <description>Comparison of pregnancy rate based on semen morphology of &lt;4% vs &gt;4% normal morphology scores.</description>
  </other_outcome>
  <other_outcome>
    <measure>Pregnancy Rate Per Body Mass Index Category</measure>
    <time_frame>Up to cycle day 35</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Day Of</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group takes either clomiphene or letrozole on cycle days 3-7 and then receives intrauterine insemination on the day the home ovulation predictor kit first turns positive.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Day After</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group takes either clomiphene or letrozole on cycle days 3-7 and then receives intrauterine insemination on the day after the home ovulation predictor kit first turns positive.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intrauterine Insemination</intervention_name>
    <description>Intrauterine insemination is either performed on the day the home ovulation predictor kit first turns positive or the day after the first positive.</description>
    <arm_group_label>Day Of</arm_group_label>
    <arm_group_label>Day After</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clomiphene</intervention_name>
    <description>Patient is to take clomiphene citrate during cycle days 3-7.</description>
    <arm_group_label>Day Of</arm_group_label>
    <arm_group_label>Day After</arm_group_label>
    <other_name>clomid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Letrozole</intervention_name>
    <description>Patient is to take letrozole during cycle days 3-7.</description>
    <arm_group_label>Day Of</arm_group_label>
    <arm_group_label>Day After</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All couples consisting of male and female partner undergoing CC or letrozole cycle
             plus IUI at a single infertility center (Midwest Fertility Specialists)

          -  The female partner must be aged 21-39

          -  Infertile couples include those with a diagnosis(s) of unexplained infertility, mild
             male factor, ovulatory dysfunction, or anovulation

          -  Evidence of a normal uterus and at least unilateral tubal patency on saline infusion
             sonogram or hysterosalpingogram within the last 2 years

          -  Semen analysis for male partner must have minimal sperm concentration of 10 million
             per milliliter

        Exclusion Criteria:

          -  Recurrent miscarriages

          -  Nursing mothers

          -  Diagnoses of primary ovarian failure, diminishing ovarian reserve (as indicated by
             blood follicle stimulating hormone &gt;10 milliInternationalUnits/mL and/or
             anti-mullerian hormone level &lt;0.5), abnormal uterine bleeding of undetermined origin,
             ovarian cyst of undetermined origin, stage IV endometriosis, or sex-hormone dependent
             tumors

          -  Documented bilateral tubal obstruction or other uncorrected uterine anomalies (e.g.
             uterine septum)

          -  Previous gonadotropin use and/or previous treatment with in vitro fertilization

          -  Abnormal semen analysis (sperm concentration less than 10 million per mL) or
             ejaculatory dysfunction in male partner

          -  Other uncorrected medical condition in female partner that would be a contraindication
             to attempting elective ovulation induction (e.g., uncontrolled diabetes, intracranial
             lesion, thyroid or adrenal disease)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew Will, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Midwest Fertility Specialists</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Midwest Fertility Specialists- Fort Wayne</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46825</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Midwest Fertility Specialists</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 1, 2014</study_first_submitted>
  <study_first_submitted_qc>November 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2014</study_first_posted>
  <results_first_submitted>September 27, 2015</results_first_submitted>
  <results_first_submitted_qc>November 4, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 9, 2015</results_first_posted>
  <last_update_submitted>November 4, 2015</last_update_submitted>
  <last_update_submitted_qc>November 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Infertility</keyword>
  <keyword>Intrauterine insemination</keyword>
  <keyword>Luteinizing hormone surge</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Letrozole</mesh_term>
    <mesh_term>Clomiphene</mesh_term>
    <mesh_term>Enclomiphene</mesh_term>
    <mesh_term>Zuclomiphene</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients recruited from two clinical offices from 1/2014 until 9/2015.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Insemination Day Of Positive OPK</title>
          <description>This group takes either clomiphene or letrozole on cycle days 3-7 and then receives intrauterine insemination on the day the home ovulation predictor kit first turns positive.
Intrauterine Insemination: Intrauterine insemination is either performed on the day the home ovulation predictor kit first turns positive or the day after the first positive.
Clomiphene: Patient is to take clomiphene citrate during cycle days 3-7.
Letrozole: Patient is to take letrozole during cycle days 3-7.</description>
        </group>
        <group group_id="P2">
          <title>Insemination Day After Positive OPK</title>
          <description>This group takes either clomiphene or letrozole on cycle days 3-7 and then receives intrauterine insemination on the day after the home ovulation predictor kit first turns positive.
Intrauterine Insemination: Intrauterine insemination is either performed on the day the home ovulation predictor kit first turns positive or the day after the first positive.
Clomiphene: Patient is to take clomiphene citrate during cycle days 3-7.
Letrozole: Patient is to take letrozole during cycle days 3-7.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Insemination Day Of Positive OPK</title>
          <description>This group takes either clomiphene or letrozole on cycle days 3-7 and then receives intrauterine insemination on the day the home ovulation predictor kit first turns positive.
Intrauterine Insemination: Intrauterine insemination is either performed on the day the home ovulation predictor kit first turns positive or the day after the first positive.
Clomiphene: Patient is to take clomiphene citrate during cycle days 3-7.
Letrozole: Patient is to take letrozole during cycle days 3-7.</description>
        </group>
        <group group_id="B2">
          <title>Insemination Day After Positive OPK</title>
          <description>This group takes either clomiphene or letrozole on cycle days 3-7 and then receives intrauterine insemination on the day after the home ovulation predictor kit first turns positive.
Intrauterine Insemination: Intrauterine insemination is either performed on the day the home ovulation predictor kit first turns positive or the day after the first positive.
Clomiphene: Patient is to take clomiphene citrate during cycle days 3-7.
Letrozole: Patient is to take letrozole during cycle days 3-7.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="7"/>
            <count group_id="B2" value="6"/>
            <count group_id="B3" value="13"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.4" spread="5.9"/>
                    <measurement group_id="B2" value="29.6" spread="3.05"/>
                    <measurement group_id="B3" value="30.1" spread="4.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30" spread="8.9"/>
                    <measurement group_id="B2" value="25" spread="4"/>
                    <measurement group_id="B3" value="27.9" spread="7.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Day 3 Follicle Stimulating Hormone</title>
          <units>mIU/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.6" spread="1.7"/>
                    <measurement group_id="B2" value="6.2" spread="1.9"/>
                    <measurement group_id="B3" value="6.9" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Anti-mullerian Hormone</title>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.1" spread="2.2"/>
                    <measurement group_id="B2" value="5.8" spread="0"/>
                    <measurement group_id="B3" value="5.2" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sperm Concentration</title>
          <units>million sperm/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32.6" spread="13.9"/>
                    <measurement group_id="B2" value="71.2" spread="39.2"/>
                    <measurement group_id="B3" value="39.4" spread="30.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sperm morphology</title>
          <units>Percent normal</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.6" spread="2.3"/>
                    <measurement group_id="B2" value="8.5" spread="2.4"/>
                    <measurement group_id="B3" value="6.2" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mid-luteal progesterone</title>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21.1" spread="16.4"/>
                    <measurement group_id="B2" value="12.1" spread="4.3"/>
                    <measurement group_id="B3" value="18.6" spread="13.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Pregnancies Achieved Per Menstrual Cycle.</title>
        <time_frame>Up to 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insemination Day Of Positive OPK</title>
            <description>This group takes either clomiphene or letrozole on cycle days 3-7 and then receives intrauterine insemination on the day the home ovulation predictor kit first turns positive.
Intrauterine Insemination: Intrauterine insemination is either performed on the day the home ovulation predictor kit first turns positive or the day after the first positive.
Clomiphene: Patient is to take clomiphene citrate during cycle days 3-7.
Letrozole: Patient is to take letrozole during cycle days 3-7.</description>
          </group>
          <group group_id="O2">
            <title>Insemination Day After Positive OPK</title>
            <description>This group takes either clomiphene or letrozole on cycle days 3-7 and then receives intrauterine insemination on the day after the home ovulation predictor kit first turns positive.
Intrauterine Insemination: Intrauterine insemination is either performed on the day the home ovulation predictor kit first turns positive or the day after the first positive.
Clomiphene: Patient is to take clomiphene citrate during cycle days 3-7.
Letrozole: Patient is to take letrozole during cycle days 3-7.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Pregnancies Achieved Per Menstrual Cycle.</title>
          <units>pregnancies per cycle</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Per Cycle Pregnancy Rate Based on Infertility Diagnosis</title>
        <time_frame>Up to cycle day 35</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insemination Day Of Positive OPK</title>
            <description>This group takes either clomiphene or letrozole on cycle days 3-7 and then receives intrauterine insemination on the day the home ovulation predictor kit first turns positive.
Intrauterine Insemination: Intrauterine insemination is either performed on the day the home ovulation predictor kit first turns positive or the day after the first positive.
Clomiphene: Patient is to take clomiphene citrate during cycle days 3-7.
Letrozole: Patient is to take letrozole during cycle days 3-7.</description>
          </group>
          <group group_id="O2">
            <title>Insemination Day After Positive OPK</title>
            <description>This group takes either clomiphene or letrozole on cycle days 3-7 and then receives intrauterine insemination on the day after the home ovulation predictor kit first turns positive.
Intrauterine Insemination: Intrauterine insemination is either performed on the day the home ovulation predictor kit first turns positive or the day after the first positive.
Clomiphene: Patient is to take clomiphene citrate during cycle days 3-7.
Letrozole: Patient is to take letrozole during cycle days 3-7.</description>
          </group>
        </group_list>
        <measure>
          <title>Per Cycle Pregnancy Rate Based on Infertility Diagnosis</title>
          <units>pregnancies per cycle</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Pregnancy Rate Per Female Partner Age</title>
        <description>Pregnancy rate will be compared between patients &lt;35 and &gt;35 at time of study entry.</description>
        <time_frame>Up to cycle day 35</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insemination Day Of Positive OPK</title>
            <description>This group takes either clomiphene or letrozole on cycle days 3-7 and then receives intrauterine insemination on the day the home ovulation predictor kit first turns positive.
Intrauterine Insemination: Intrauterine insemination is either performed on the day the home ovulation predictor kit first turns positive or the day after the first positive.
Clomiphene: Patient is to take clomiphene citrate during cycle days 3-7.
Letrozole: Patient is to take letrozole during cycle days 3-7.</description>
          </group>
          <group group_id="O2">
            <title>Insemination Day After Positive OPK</title>
            <description>This group takes either clomiphene or letrozole on cycle days 3-7 and then receives intrauterine insemination on the day after the home ovulation predictor kit first turns positive.
Intrauterine Insemination: Intrauterine insemination is either performed on the day the home ovulation predictor kit first turns positive or the day after the first positive.
Clomiphene: Patient is to take clomiphene citrate during cycle days 3-7.
Letrozole: Patient is to take letrozole during cycle days 3-7.</description>
          </group>
        </group_list>
        <measure>
          <title>Pregnancy Rate Per Female Partner Age</title>
          <description>Pregnancy rate will be compared between patients &lt;35 and &gt;35 at time of study entry.</description>
          <units>pregnancies per cycle</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Female age &lt; 35</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Female age &gt; 35</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Pregnancy Rate Per Semen Morphology Score</title>
        <description>Comparison of pregnancy rate based on semen morphology of &lt;4% vs &gt;4% normal morphology scores.</description>
        <time_frame>Up to cycle day 35</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insemination Day Of Positive OPK</title>
            <description>This group takes either clomiphene or letrozole on cycle days 3-7 and then receives intrauterine insemination on the day the home ovulation predictor kit first turns positive.
Intrauterine Insemination: Intrauterine insemination is either performed on the day the home ovulation predictor kit first turns positive or the day after the first positive.
Clomiphene: Patient is to take clomiphene citrate during cycle days 3-7.
Letrozole: Patient is to take letrozole during cycle days 3-7.</description>
          </group>
          <group group_id="O2">
            <title>Insemination Day After Positive OPK</title>
            <description>This group takes either clomiphene or letrozole on cycle days 3-7 and then receives intrauterine insemination on the day after the home ovulation predictor kit first turns positive.
Intrauterine Insemination: Intrauterine insemination is either performed on the day the home ovulation predictor kit first turns positive or the day after the first positive.
Clomiphene: Patient is to take clomiphene citrate during cycle days 3-7.
Letrozole: Patient is to take letrozole during cycle days 3-7.</description>
          </group>
        </group_list>
        <measure>
          <title>Pregnancy Rate Per Semen Morphology Score</title>
          <description>Comparison of pregnancy rate based on semen morphology of &lt;4% vs &gt;4% normal morphology scores.</description>
          <units>pregnancies per cycle</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Semen morphology &lt; 4%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Semen morphology &gt; 4%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Pregnancy Rate Per Body Mass Index Category</title>
        <time_frame>Up to cycle day 35</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Insemination Day Of Positive OPK</title>
            <description>This group takes either clomiphene or letrozole on cycle days 3-7 and then receives intrauterine insemination on the day the home ovulation predictor kit first turns positive.
Intrauterine Insemination: Intrauterine insemination is either performed on the day the home ovulation predictor kit first turns positive or the day after the first positive.
Clomiphene: Patient is to take clomiphene citrate during cycle days 3-7.
Letrozole: Patient is to take letrozole during cycle days 3-7.</description>
          </group>
          <group group_id="O2">
            <title>Insemination Day After Positive OPK</title>
            <description>This group takes either clomiphene or letrozole on cycle days 3-7 and then receives intrauterine insemination on the day after the home ovulation predictor kit first turns positive.
Intrauterine Insemination: Intrauterine insemination is either performed on the day the home ovulation predictor kit first turns positive or the day after the first positive.
Clomiphene: Patient is to take clomiphene citrate during cycle days 3-7.
Letrozole: Patient is to take letrozole during cycle days 3-7.</description>
          </group>
        </group_list>
        <measure>
          <title>Pregnancy Rate Per Body Mass Index Category</title>
          <units>pregnancies per cycle</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Body mass index normal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Body mass index overweight</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Body mass index obese</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Insemination Day Of Positive OPK</title>
          <description>This group takes either clomiphene or letrozole on cycle days 3-7 and then receives intrauterine insemination on the day the home ovulation predictor kit first turns positive.
Intrauterine Insemination: Intrauterine insemination is either performed on the day the home ovulation predictor kit first turns positive or the day after the first positive.
Clomiphene: Patient is to take clomiphene citrate during cycle days 3-7.
Letrozole: Patient is to take letrozole during cycle days 3-7.</description>
        </group>
        <group group_id="E2">
          <title>Insemination Day After Positive OPK</title>
          <description>This group takes either clomiphene or letrozole on cycle days 3-7 and then receives intrauterine insemination on the day after the home ovulation predictor kit first turns positive.
Intrauterine Insemination: Intrauterine insemination is either performed on the day the home ovulation predictor kit first turns positive or the day after the first positive.
Clomiphene: Patient is to take clomiphene citrate during cycle days 3-7.
Letrozole: Patient is to take letrozole during cycle days 3-7.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Matt Will or Dr. Lauren Messinger</name_or_title>
      <organization>Midwest Fertility Specialists or St. Vincent Women's Hospital</organization>
      <phone>317-415-7528</phone>
      <email>laurenmessinger@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

